Stocks and Investing
Stocks and Investing
Wed, February 28, 2024
[ 12:00 AM ] - WOPRAI
Tue, February 27, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Brian Cheng Maintained (ALLO) at Buy with Decreased Target to $8 on, Feb 27th, 2024
Brian Cheng of JP Morgan, Maintained "Allogene Therapeutics, Inc." (ALLO) at Buy with Decreased Target from $9 to $8 on, Feb 27th, 2024.
Brian has made no other calls on ALLO in the last 4 months.
There are 4 other peers that have a rating on ALLO. Out of the 4 peers that are also analyzing ALLO, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Michael Schmidt of "Guggenheim" Downgraded from Strong Buy to Hold on, Friday, January 5th, 2024
- Reni Benjamin of "JMP Securities" Downgraded from Buy to Hold on, Friday, January 5th, 2024
These are the ratings of the 2 analyists that currently disagree with Brian
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $10 on, Friday, January 19th, 2024
- Samantha Semenkow of "Citigroup" Initiated at Strong Buy and Held Target at $7 on, Friday, December 8th, 2023
Contributing Sources